| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Product sales, net | |||||||||
8,374 | 9,622 | 11,281 | - | - | - | - | - | - | - |
Cost of products sold | |||||||||
2,656 | 5,190 | 4,312 | - | - | - | - | - | - | - |
Product sales, net | |||||||||
- | - | - | 10,482 | 9,491 | 10,333 | 10,011 | 8,648 | 8,378 | 9,749 |
Cost of products sold | |||||||||
- | - | - | 4,175 | 3,048 | 3,630 | 3,198 | 3,055 | 3,016 | 3,531 |
Gross profit | |||||||||
5,718 | 4,431 | 6,969 | 6,306 | 6,443 | 6,702 | 6,812 | 5,592 | 5,361 | 6,218 |
Selling, general and administrative expenses | |||||||||
9,527 | 10,645 | 11,930 | 11,549 | 9,399 | 7,404 | 5,534 | 5,930 | 6,445 | 6,648 |
Research and development expenses | |||||||||
189 | 245 | 272 | 1,270 | 100 | 88 | 191 | 181 | 140 | 270 |
Impairment to long lived assets | |||||||||
- | 1,539 | - | - | - | - | - | - | - | - |
Total operating expenses | |||||||||
9,717 | 12,430 | 12,203 | 12,820 | 9,500 | 7,492 | 5,725 | 6,112 | 6,585 | 6,919 |
Loss from operations | |||||||||
-3,998 | -7,999 | -5,234 | -6,513 | -3,056 | -790 | 1,086 | -520 | -1,223 | -700 |
Other expenses | |||||||||
-10 | -7 | -4 | -5 | -5 | - | - | - | - | 183 |
Interest income | |||||||||
1 | 7 | - | - | - | - | - | - | - | - |
Change in fair value of derivative liability | |||||||||
-3,635 | - | - | - | - | - | - | - | - | - |
Other income | |||||||||
- | - | - | - | - | - | 17 | - | - | - |
Interest income | |||||||||
- | - | 9 | 1 | 3 | 2 | 0 | 0 | 0 | 0 |
Interest expense | |||||||||
- | - | - | - | - | - | 70 | 175 | 131 | 95 |
Gain on Dilutive Effect on Medical Joint Venture stock issuance | |||||||||
- | - | - | - | - | - | 1,363 | - | - | - |
Total other expenses, net | |||||||||
- | - | - | - | - | 2 | 378 | - | - | - |
Loss before provision for income taxes and net of equity investments | |||||||||
-7,643 | -7,999 | -5,229 | -6,517 | -3,058 | -787 | - | - | - | - |
(Loss) income before provision for income taxes | |||||||||
- | - | - | - | - | - | 1,464 | - | - | - |
Provision for income taxes | |||||||||
18 | 23 | 19 | -19 | 36 | 9 | - | 0 | - | - |
Loss before equity in net earnings (losses) of equity investments | |||||||||
-7,661 | -8,023 | -5,249 | -6,498 | -3,094 | -797 | - | - | - | - |
Interest-Amortized debt issuance - cost | |||||||||
- | - | - | - | - | - | - | 3 | 5 | 2 |
Earnings from China Joint Venture | |||||||||
81 | 329 | -120 | -795 | -2,445 | -910 | - | -171 | -121 | - |
(Loss) Earnings on earnings from equity method investment | |||||||||
81 | 329 | -120 | -795 | - | -910 | - | -171 | -121 | - |
Net loss | |||||||||
-7,580 | -7,691 | -5,369 | -7,294 | -5,539 | -1,707 | 1,464 | -870 | - | - |
Net loss attributable to noncontrolling interests | |||||||||
-55 | -260 | -182 | -1,347 | -72 | -5 | - | - | - | - |
Total other expenses, net | |||||||||
- | - | - | - | - | - | - | 349 | 258 | - |
Total other expenses | |||||||||
- | - | - | - | - | - | - | - | - | 86 |
Net loss attributable to Milestone Scientific Inc. | |||||||||
-7,524 | -7,431 | -5,186 | -5,946 | -5,467 | -1,702 | 1,464 | -870 | -1,482 | -614 |
Net loss per share applicable to common stockholders— | |||||||||
Basic (in dollars per share) | |||||||||
-0.16 | -0.21 | -0.16 | -0.22 | -0.26 | -0.08 | 0.09 | -0.05 | - | - |
Diluted (in dollars per share) | |||||||||
-0.16 | -0.21 | -0.16 | -0.22 | -0.26 | -0.08 | 0.08 | -0.05 | - | - |
Weighted average shares outstanding and to be issued— | |||||||||
Basic (in shares) | |||||||||
45,740 | 35,299 | 32,703 | 26,966 | 21,429 | 20,063 | 17,127 | 16,080 | - | - |
Diluted (in shares) | |||||||||
45,740 | 35,299 | 32,703 | 26,966 | 21,429 | 20,063 | 17,483 | 16,080 | - | - |
Net loss applicable to common stockholders | |||||||||
-7,524 | -7,431 | -5,186 | -5,946 | - | - | - | - | - | -614 |
Loss per share applicable to common stockholders - basic and diluted | |||||||||
- | - | - | - | - | - | - | - | -0.10 | -0.04 |
Weighted average shares outstanding and to be issued - basic and diluted | |||||||||
- | - | - | - | - | - | - | - | 15,174 | - |
Weighted average shares outstanding and to be issued - Basic and diluted | |||||||||
- | - | - | - | - | - | - | - | - | 14,824 |
Milestone Education LLC [Member] | |||||||||
Loss from earnings on China joint venture | |||||||||
- | 1 | - | - | - | - | - | - | - | - |
(Loss) Earnings on earnings from equity method investment | |||||||||
- | 1 | - | - | - | - | - | - | - | - |
China Joint Venture [Member] | |||||||||
Loss from earnings on China joint venture | |||||||||
81 | 329 | -120 | - | - | - | - | - | - | - |
(Loss) Earnings on earnings from equity method investment | |||||||||
81 | 329 | -120 | - | - | - | - | - | - | - |